Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GX G6

Next Previous
Drug Profile

GX G6

Alternative Names: GLP1-hyFc; GX-G6; HyGlutide; Long-acting glucagon-like peptide-1 - Genexine; Recombinant-GLP1-fusion-protein; Recombinant-glucagon-like-peptide-1-fusion-protein; TG 103; TJ 103

Latest Information Update: 11 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genexine
  • Developer CSPC Pharma; Genexine
  • Class Antihyperglycaemics; Glucagon-like peptides; Hormones; Recombinant fusion proteins
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Obesity
  • Phase II Type 2 diabetes mellitus

Most Recent Events

  • 30 Oct 2025 I-MAB Biopharma is now called NovaBridge Biosciences
  • 24 Oct 2024 CSPC Pharma completes a phase II trial in Obesity in China (SC) (NCT06226090)
  • 21 Feb 2024 CSPC Pharma initiates enrolment in a phase II trial for Obesity in China (SC) (NCT06226090)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top